Save
Email
Print
Share
RSSBrowse News Stories
281 to 290 of 304 stories
view headlines only
-
Retroviral Protein Triggers Proliferation Of Immune Cells
October 23, 2003 — Scientists here have found that a protein in the retrovirus known as human T-cell lymphotropic virus type 1 (HTLV-1) can cause immune cells to divide and proliferate, helping the virus spread through ... > full story -
Study Finds Potential Way To Improve Cancer Immunotherapy
September 5, 2003 — Drugs that contain antibodies are a standard part of therapy for many cancers, but these antibodies do not always work. A finding by researchers with the Holden Comprehensive Cancer Center at the ... > full story -
Gene That Is Crucial For Antibody-Producing Cell Development Is Key To Blood Cell Cancer
August 29, 2003 — A gene that is crucial to the development and function of an entire family of immune cells is also key to understanding why one member of that family can become cancerous. Investigators at St. Jude ... > full story -
Targeted Immunotherapy Eradicates Cancer In Mice; May Have Potential Value In Treating Patients With Hematologic Cancers
February 10, 2003 — Researchers have developed a novel approach to genetically instruct human immune cells to recognize and kill cancer cells in a mouse model. The investigators plan to ultimately apply this strategy in ... > full story -
Smoking May Change Type Of Lymphoma Into More Lethal Form Of Cancer
November 4, 2002 — A Northwestern University investigator has hypothesized that smoking may play a dual role in the development of a cancer of the lymph glands called follicular lymphoma -- first causing it to develop ... > full story -
New Study Shows Passive Cigarette Smoke At Least Doubles Risk Of Cancer In Cats
July 30, 2002 — Cats living in homes where people smoke cigarettes are more than twice as likely as other cats to acquire a deadly form of cancer known as feline lymphoma, according to a first-of-its kind study in ... > full story -
Gene Expression Profiles Predict Survival Of Lymphoma Patients After Chemotherpy
June 20, 2002 — Patterns of genes that are active in tumor cells can predict whether patients with diffuse large B-cell lymphoma (DLBCL) are likely to be cured by chemotherapy, scientists report in the New England ... > full story -
Jefferson Scientists Create First Animal Model Of Common Type Of Leukemia
May 22, 2002 — Researchers at Jefferson Medical College and the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia have developed the first animal model of the most common type of human leukemia. ... > full story -
New Radioimmunotherapy Drug Proves Highly Effective For Killing Off B Cell Non-Hodgkin's Lymphoma
May 14, 2002 — A Mayo Clinic study indicates the first of a new class of drugs involving radioimmunotherapy benefited a significant number of patients with low-grade B cell non-Hodgkin’s lymphoma who have ... > full story -
Researchers Test Custom-Made Vaccine For Non-Hodgkin's Lymphoma; Approach Uses Patient's Own Tumor Cells To Harness Immune System
April 29, 2002 — As part of a national multi-center study, researchers at the University of Maryland Greenebaum Cancer Center in Baltimore are testing a custom-made vaccine for low-grade non-Hodgkin’s lymphoma ... > full story
Search ScienceDaily
Number of stories in archives: 137,222
more 
